2023 Texas Lung Cancer Conference Coverage

 

2023 Texas Lung Cancer Conference Coverage
Avatar

The Evolving Role of Dual Checkpoint Inhibition in Advanced NSCLC

By 2023 Texas Lung Cancer Conference Coverage FEATURING Hossein Borghaei
By 2023 Texas Lung Cancer Conference Coverage FEATURING Hossein Borghaei
121 views
May 25, 2023
Comments 0
Login to view comments. Click here to Login

Featured Video

09:36
Johnson & Johnson

Mechanisms of Resistance in Locally Advanced or Metastatic EGFR+ NSC…

Feat. J. Heymach, M. Das

Featured Video

08:44
Johnson & Johnson

Management and Proactive Care of Adverse Events Associated with Loca…

Feat. J. Sabari, A. Spira
Videos
22:46

When Is PD(L)1 Monotherapy for NSCLC Enough?

2023 Texas Lung Cancer Conference Coverage

S. Gadgeel

51 views
21:34

The Evolving Role of Dual Checkpoint Inhibition in Advanced NSCLC

2023 Texas Lung Cancer Conference Coverage

H. Borghaei

121 views
15:46

Targeted Therapy for RET NSCLC

2023 Texas Lung Cancer Conference Coverage

E. Santos​

88 views
08:14

Updates in Malignant Pleural Mesothelioma

2023 Texas Lung Cancer Conference Coverage

M. Marmarelis

210 views
20:34

Current Role of Adjuvant IO in NSCLC

2023 Texas Lung Cancer Conference Coverage

J. Donington

139 views
16:29

How to Incorporate Liquid Biopsy for NSCLC in Practice

2023 Texas Lung Cancer Conference Coverage

L. Raez

328 views
17:57

Advantages of Chemoimmunotherapy for NSCLC

2023 Texas Lung Cancer Conference Coverage

M. Johnson

148 views